Pratt C B, Crom D B, Howarth C
Med Pediatr Oncol. 1985;13(6):330-3. doi: 10.1002/mpo.2950130606.
Among the 114 children with retinoblastoma seen at St. Jude Children's Research Hospital 1962-1984, 11 have received treatment with chemotherapy for measurable extraocular disease which was present at diagnosis (seven patients) or developed later during the subsequent course of their disease (four patients). Metastatic disease involved the brain and spinal fluid of four persons, the orbit of five, the bone marrow of five, lymph nodes of four, and soft tissues of three individuals at the time of their treatments. Single agents or combinations were used. Two patients with orbital extension of primary retinoblastoma developed complete responses following chemotherapy and subsequently received orbital irradiation, and have had long-term disease-free survival. Additional responses developed in patients who received vincristine, cyclophosphamide, adriamycin, cisplatin, VM-26, and ifosfamide, singly or in combination. With future identification of effective chemotherapy, new studies may be focused upon patients with localized disease to reduce radiation dosage or the need for immediate surgical resection of all involved eyes.
在1962年至1984年间于圣裘德儿童研究医院就诊的114例视网膜母细胞瘤患儿中,有11例因在诊断时(7例患者)或疾病后续过程中后来出现(4例患者)的可测量眼外疾病而接受了化疗。在接受治疗时,转移性疾病累及4人的脑和脑脊液、5人的眼眶、5人的骨髓、4人的淋巴结以及3人的软组织。使用了单一药物或联合用药。2例原发性视网膜母细胞瘤眼眶扩展的患者在化疗后出现完全缓解,随后接受了眼眶放疗,并实现了长期无病生存。接受长春新碱、环磷酰胺、阿霉素、顺铂、VM - 26和异环磷酰胺单药或联合用药的患者也出现了其他缓解情况。随着未来有效化疗药物的确定,新的研究可能会聚焦于局限性疾病患者,以减少辐射剂量或减少立即手术切除所有受累眼睛的必要性。